Harrow Health (HROW) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts HROW Hot Sheet
Join SI Premium – FREE
(Updated - May 11, 2023 4:28 PM EDT)
Harrow Health (NASDAQ: HROW) reported Q1 EPS of ($0.03), in-line with the analyst estimate of ($0.03). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $24.97 million.
For earnings history and earnings-related data on Harrow Health (HROW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Cummins wins battery storage contract for U.S. data center project
- Palogic urges Granite Point Mortgage to cut costs, halt new loans
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
